LabGenomics is headquartered in Seongnam-si, South Korea.
LabGenomics disclosed revenue of 85,898M KRW for 2024 and 71,076M KRW for 2023.
LabGenomics is a life science company.
LabGenomics was founded in 2002.
700 Daewangpangyo-ro, Korea Bio Park Bldg. 6F-B,
Seongnam-si,
463-400
South Korea,
www.labgenomics.co.kr
LabGenomics is a healthcare company specializing in molecular diagnostics. LabGenomics offers several cancer tests, including ‘BRCA1/BRCA2,’ ‘comprehensive genetic cancer panel,’ and ‘OTD-Solid’ test. LabGenomics was formed in 2002 and is based in Seongnam-si, South Korea.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.4/yr) | # | - | - | - | 1 | 1 | - | 2 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 2 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
